Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3

被引:135
作者
Teiber, JF [1 ]
Draganov, DI [1 ]
La Du, BN [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA
关键词
paraoxonase; lactones; lactonase; lactonization; 5-hydroxyeicosatetraenoic acid; 4-hydroxydocosahexaenoic acid;
D O I
10.1016/S0006-2952(03)00401-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Human paraoxonase (PON1) was previously shown to hydrolyze over 30 different lactones (cyclic esters). In the present study purified human PON1 was found to catalyze the reverse reaction (lactonization) of a broad range of hydroxy acids. Hydroxy acid lactonization or lactone hydrolysis is catalyzed until equilibrium between the open and closed forms is reached. Lactonization by PON1 was calcium-dependent, had a pH optimum of 5.5-6 and could be stimulated with dilauroylphosphatidylcholine. Rabbit serum PON3 and a serine esterase in mouse plasma, presumably a carboxylesterase, also catalyzed hydroxy acid lactonization. Two endogenous oxidized unsaturated fatty acids, (+/-)4-hydroxy-5E,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid (4-HDoHE) and (+/-)5-hydroxy-6E,8Z,11Z,14Z-eicosatetraenoic acid (5-HETE) lactone, were very efficiently lactonized and hydrolyzed, respectively, by PON1. Human and mouse plasma samples also catalyzed 4-HDoHE lactonization and 5-HETE lactone hydrolysis. Studies with the PON1 inhibitor EDTA and the serine esterase inhibitor phenyl methyl sulfonyl fluoride suggest that about 80-95% of both activities can be attributed to PONI in the human samples. In the mouse sample, PON1 accounted for about 30% of the 4-HDoHE lactonizing activity and 72% of the 5-HETE lactonase activity. Our results demonstrate that PON1 can lactonize the hydroxy acid form of its lactone substrates and that reversible hydrolysis of lactones may be a property of lactonases that is not generally considered. Also, the high activity of PON1 towards 4-HDoHE and 5-HETE lactone suggests that oxidized eicosanoids and docosanoids may be important physiological substrates for PON1. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:887 / 896
页数:10
相关论文
共 44 条
[1]   The FEMA GRAS assessment of lactones used as flavour ingredients [J].
Adams, TB ;
Greer, DB ;
Doull, J ;
Munro, IC ;
Newberne, P ;
Portoghese, PS ;
Smith, RL ;
Wagner, BM ;
Weil, CS ;
Woods, LA ;
Ford, RA .
FOOD AND CHEMICAL TOXICOLOGY, 1998, 36 (04) :249-278
[2]  
ADKINS S, 1993, AM J HUM GENET, V52, P598
[3]   Multiple substrates for paraoxonase-1 during oxidation of phosphatidylcholine by peroxynitrite [J].
Ahmed, Z ;
Ravandi, A ;
Maguire, GF ;
Emili, A ;
Draganov, D ;
La Du, BN ;
Kuksis, A ;
Connelly, PW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 290 (01) :391-396
[4]   Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities - Selective action of human paraoxonase allozymes Q and R [J].
Aviram, M ;
Billecke, S ;
Sorenson, R ;
Bisgaier, C ;
Newton, R ;
Rosenblat, M ;
Erogul, J ;
Hsu, C ;
Dunlop, C ;
La Du, B .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (10) :1617-1624
[5]   Selective plasma hydrolysis of glucocorticoid γ-lactones and cyclic carbonates by the enzyme paraoxonase:: An ideal plasma inactivation mechanism [J].
Biggadike, K ;
Angell, RM ;
Burgess, CM ;
Farrell, RM ;
Hancock, AP ;
Harker, AJ ;
Irving, WR ;
Ioannou, C ;
Procopiou, PA ;
Shaw, RE ;
Solanke, YE ;
Singh, OMP ;
Snowden, MA ;
Stubbs, RJ ;
Walton, S ;
Weston, HE .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (01) :19-21
[6]  
Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335
[7]   The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin [J].
Davies, HG ;
Richter, RJ ;
Keifer, M ;
Broomfield, CA ;
Sowalla, J ;
Furlong, CE .
NATURE GENETICS, 1996, 14 (03) :334-336
[8]   Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation [J].
Draganov, DI ;
Stetson, PL ;
Watson, CE ;
Billecke, SS ;
La Du, BN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (43) :33435-33442
[9]  
DUGGAN DE, 1989, DRUG METAB DISPOS, V17, P166
[10]   Iodolactones and iodoaldehydes - Mediators of iodine in thyroid autoregulation [J].
Dugrillon, A .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1996, 104 :41-45